Cell lines are fundamental tools across life science research, supporting work in areas such as cancer biology, drug discovery, toxicology, genetics and disease modelling. However, experimental reliability depends heavily on the quality and identity of the biological material being used. Authentication, contamination screening, documentation and access to suitable cell models can therefore be important considerations when choosing a supplier.
The following six cell line providers support researchers with established cell collections, specialist models and related services.
1. Cytion
Cytion provides authenticated human and animal cell lines for academic, biotechnology and pharmaceutical research. Its catalogue contains more than 1,000 authenticated cell lines, including tumour models, immortalized normal cells, reporter and stably transfected derivatives, induced pluripotent stem cells (iPSCs) and mesenchymal stromal cells.
Quality control is a major part of Cytion’s offering. Cell lines undergo identity and contamination checks, including STR profiling where applicable and mycoplasma screening. Cytion also operates under an ISO 9001:2015-certified quality management system.
Alongside its catalogue, Cytion provides services including STR authentication, mycoplasma testing, cell expansion and cell banking, making it a useful option for laboratories seeking both research models and ongoing cell culture support.
2. ATCC
ATCC is an established biological resource organization supplying cell lines and other research materials. Its collections are widely used across biomedical research, with models available for fields ranging from oncology and infectious disease to genetics and drug development.
Authentication and quality control are central to its cell line resources. ATCC performs authentication and quality-control testing on distribution lots and also provides technical guidance to help laboratories maintain reliable cell cultures.
3. Creative Bioarray
Creative Bioarray offers human and animal cell lines alongside primary cells and stem cells. Its portfolio covers numerous research areas, including cancer research, drug discovery and disease modelling.
Researchers can also access specialized options such as tumour cell panels and stable cell lines. Its tumour panels combine characterized cell lines with mutation information, which can be useful when selecting models for targeted oncology studies.
4. AcceGen
AcceGen supplies a broad selection of cell-based research products. Its catalogue includes human and animal primary cells, tumour cell lines, stem cells, immortalized cell lines and transfected stable cell lines.
The availability of knockout, knock-in, knockdown and overexpression stable cell lines also makes the provider relevant to researchers studying gene function and developing more specialized experimental systems.
5. AddexBio
AddexBio provides cancer, immortalized, normal, primary and stable cell lines for research applications. Its cancer collection spans numerous tissue and disease types, while its immortalized models include commonly used research cells such as HEK-293, HaCaT and COS-7.
The company also offers associated cell authentication and mycoplasma testing services.
6. DSMZ
DSMZ maintains a substantial collection of human and animal cell lines used across international research. Its catalogue includes models for areas such as leukaemia, lymphoma, myeloma and solid-tumour research, alongside animal-derived lines.
Its searchable catalogue and biological-resource focus make DSMZ another established source for researchers looking for well-documented cell models.
Choosing a Cell Line Provider
The right provider will depend on the required model, application and laboratory workflow. Researchers may want to compare authentication procedures, contamination testing, documentation, culture guidance and availability of specialized models before ordering. Choosing well-characterized cells from a provider with appropriate quality controls can help establish a stronger foundation for reproducible life science research.
